Stryker (SYK) Total Current Liabilities (2009 - 2026)
Stryker's (SYK) quarterly Total Current Liabilities came in at $6.3 billion in Q1 2026, down 20.36% year-on-year from $7.9 billion in Q1 2025, and down 18.98% on a QoQ basis from $7.8 billion in Q4 2025.
Stryker (SYK) Total Current Liabilities (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Total Current Liabilities data on file, last reported at $6.3 billion in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 20.36% year-over-year to $6.3 billion in Q1 2026; TTM through Mar 2026 was $6.3 billion, a 20.36% decrease from a year earlier, with the FY2025 full-year figure at $7.8 billion, up 2.34% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $6.3 billion, down from $7.8 billion in the prior quarter.
- Over the last five years, Total Current Liabilities for SYK reached as high as $7.9 billion in Q1 2025 and fell as low as $4.4 billion in Q2 2022.
- Historically, Total Current Liabilities has averaged $6.7 billion across 5 years, with a median of $7.0 billion in 2024.
- Across the five-year window, Total Current Liabilities soared 63.16% in 2023 and dropped 20.36% in 2026, its largest moves.
- Year by year, Total Current Liabilities stood at $6.3 billion in 2022, then advanced by 25.67% to $7.9 billion in 2023, then fell by 3.85% to $7.6 billion in 2024, then increased by 2.34% to $7.8 billion in 2025, then dropped by 18.98% to $6.3 billion in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $6.3 billion in Q1 2026, $7.8 billion in Q4 2025, and $7.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 1.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.32 Bn |
| Dec 31, 2025 | 7.79 Bn |
| Sep 30, 2025 | 7.41 Bn |
| Jun 30, 2025 | 7.29 Bn |
| Mar 31, 2025 | 7.93 Bn |
| Dec 31, 2024 | 7.62 Bn |
| Sep 30, 2024 | 7.67 Bn |
| Jun 30, 2024 | 6.93 Bn |
| Mar 31, 2024 | 6.96 Bn |
| Dec 31, 2023 | 7.92 Bn |
| Sep 30, 2023 | 7.46 Bn |
| Jun 30, 2023 | 6.58 Bn |
| Mar 31, 2023 | 5.87 Bn |
| Dec 31, 2022 | 6.30 Bn |
| Sep 30, 2022 | 4.57 Bn |
| Jun 30, 2022 | 4.40 Bn |
| Mar 31, 2022 | 4.41 Bn |
| Dec 31, 2021 | 4.55 Bn |
| Sep 30, 2021 | 4.45 Bn |
| Jun 30, 2021 | 4.25 Bn |